Boston Scientific To Market Celsion’s Prolieve BPH Device Immediately

Boston Scientific will promote Celsion's Prolieve microwave urethroplasty system as a less-painful alternative to existing treatments for benign prostatic hyperplasia (BPH), following FDA approval Feb. 19

More from Archive

More from Medtech Insight